2021 – Precision Medicine linked with Genomic Medicine: A Work in Progress
2021 – A true testimony that we sit at the intersection of significant new opportunities The significant opportunities at the intersection of
2021 – A true testimony that we sit at the intersection of significant new opportunities The significant opportunities at the intersection of
2021 – A True Testimony that we Sit at The Intersection of Significant New Opportunities The significant opportunities at the intersection of
AGBT 2021 took place virtually this year! But the conference was nevertheless the attention grabber of the week with a twitter storm, active
New, qualitive report provides an in-depth analysis across the complex, multi-step clinical genomics data process, including genomic data generation
A young man named Aspyn Palatnick, now 22, has spent the last eight years programming the world’s first mobile genome sequence analyzer. He started
Current methods for determining RNA structure with short-read sequencing cannot capture most differences between distinct transcript isoforms.
Structural variants (SVs) may be an underestimated cause of hereditary cancer syndromes given the current limitations of short-read next-generation
End-to-end solution will enable mass/on-demand screening to support the re-opening of global economies. Group 42 (G42), a leading AI and Cloud
Welcome to the Sequencing 101 blog series – where we will provide introductions to sequencing technology, genomics, and much more! If you’re not
For the first time in three years AGBT returned to Marco Island for its 2019 conference. It was pleasant to be back and be able to enjoy the warmth
For the first time in three years AGBT returned to Marco Island for its 2019 conference. It was pleasant to be back and be able to enjoy the warmth
Oxford Nanopore has launched new ‘109’ cDNA Kits for its real-time, scalable sequencing technology. The new kits provide high throughput whilst